HR0163LRB103 31459 MST 59200 r

1
HOUSE RESOLUTION

 
2    WHEREAS, Respiratory Syncytial Virus disease (RSV) is a
3highly transmissible, seasonal virus that can have severe and
4unpredictable outcomes for infants, including hospitalization;
5and
 
6    WHEREAS, Nearly all children will be infected with RSV by
7age two, and most infants requiring hospitalization were
8previously healthy and born at term; and
 
9    WHEREAS, RSV is the leading cause of hospitalization among
10infants in the U.S.; and
 
11    WHEREAS, RSV is the most common cause of bronchiolitis
12(inflammation of the small airways in the lung) and pneumonia
13(infection of the lungs) in children younger than one year of
14age in the U.S.; and
 
15    WHEREAS, The current RSV season has resulted in
16significant morbidity and increased mortality; and
 
17    WHEREAS, In the U.S., RSV infections typically occur
18during late fall, winter, and early spring, which means urgent
19preparation is needed; and
 

 

 

HR0163- 2 -LRB103 31459 MST 59200 r

1    WHEREAS, Monoclonal antibodies show promise in
2preventative protection against RSV; and
 
3    WHEREAS, RSV disproportionally affects infants with
4Medicaid coverage, Native Americans, and Alaskan Natives; and
 
5    WHEREAS, The Vaccines For Children (VFC) program is a
6federally-funded program that provides vaccines at no cost to
7children who might not otherwise be vaccinated because of
8inability to pay; and
 
9    WHEREAS, VFC coverage is critical to ensure equity and
10access for all infants in order to have the greatest impact on
11disease burden; therefore, be it
 
12    RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE
13HUNDRED THIRD GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that
14we urge the Centers for Disease Control and Prevention to
15include new RSV immunization technologies (including vaccines
16and monoclonal antibodies), within the federal VFC program if
17the Advisory Committee on Immunization Practices of the
18Centers for Disease Control and Prevention issues
19administrative recommendations that are subsequently approved
20by the Director of the Centers for Disease Control and
21Prevention; and be it further
 

 

 

HR0163- 3 -LRB103 31459 MST 59200 r

1    RESOLVED, That suitable copies of this resolution be
2delivered to Director of the Centers for Disease Control and
3Prevention Rochelle Walensky, Administrator of the Centers for
4Medicare and Medicaid Services (CMS) Chiquita Brooks-LaSure,
5and Secretary of the Department of Health and Human Services
6Xavier Becerra.